Clinical trial
A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the…
NCT00414466 · MedtronicNeuro, Industry · Terminated
Key facts
| NCT number | NCT00414466 |
|---|---|
| Title | A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain |
| Official title | A Randomized Double Blind, Placebo-controlled, Dose Response Study of Intraspinal Gabapentin (MDT2004) in Subjects With Chronic, Intractable Pain. |
| Lead sponsor | MedtronicNeuro, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Intractable Pain |
| Intervention type | Drug |
| Interventions | Intraspinal Gabapentin |
| Enrollment | 254 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Aug 1, 2010 |
| First posted | Dec 21, 2006 |
| Last update posted | Aug 23, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: